Peripheral Vascular Devices Market to Reach USD 20.7 Billion by 2033, Fueled by Rising Cardiovascular Disorders

Market Overview:

According to IMARC Group's latest research publication, "Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global peripheral vascular devices market size reached USD 12.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How AI is Reshaping the Future of Peripheral Vascular Devices Market

• AI enhances peripheral artery disease detection through machine learning algorithms that analyze patient data, improving diagnostic accuracy by 25% and enabling early intervention strategies for better outcomes.
• Artificial intelligence optimizes angioplasty procedures with real-time image analysis and automated catheter navigation, reducing procedure time by 15% and minimizing complications in vascular interventions.
• Companies like Boston Scientific and Medtronic integrate AI-powered imaging systems in peripheral vascular devices, with 35% of new stent placements utilizing predictive analytics for optimal positioning.
• AI-driven patient monitoring systems track post-procedure recovery and predict complications, reducing hospital readmissions by 20% and improving long-term treatment success rates.
• Machine learning algorithms enhance drug-coated balloon performance through personalized dosing recommendations, achieving 58% five-year freedom from reintervention procedures for peripheral artery disease patients.

Claim Your Free "Peripheral Vascular Devices Market" Insights Sample PDF

Key Trends in the Peripheral Vascular Devices Market

• Rising Demand for Minimally Invasive Procedures: Healthcare providers increasingly favor minimally invasive peripheral vascular interventions due to reduced recovery times and lower complication rates. Atherectomy systems, stents, and angioplasty balloons are gaining momentum, with the minimally invasive surgery devices market expanding from USD 14.06 billion in 2023 to an expected USD 28.48 billion by 2032.
• Technological Innovations in Vascular Devices: Enhanced imaging techniques, drug-coated balloons, and bioresorbable stents are revolutionizing peripheral vascular disease treatment. Drug-coated balloons achieved 58% five-year freedom from reintervention procedures for in-stent restenosis, significantly improving patient outcomes and reducing repeat procedures.
• Integration of Digital Health Solutions: Remote monitoring and data analytics are enhancing chronic vascular disorder management. Healthcare providers utilize connected devices and telemedicine platforms to track patient progress, optimize treatment protocols, and enable real-time clinical decision-making for peripheral artery disease patients.
• Growing Focus on Patient-Specific Treatments: Personalized medicine approaches are driving innovation in peripheral vascular devices. Manufacturers are developing customizable stents, targeted drug delivery systems, and adaptive treatment protocols tailored to individual patient anatomy and disease severity.
• Expansion in Ambulatory Care Settings: Shift toward outpatient peripheral vascular procedures is increasing demand for portable and user-friendly devices. Ambulatory care centers are growing as preferred treatment locations, offering cost-effective care with specialized equipment designed for same-day discharge protocols.

Growth Factors in the Peripheral Vascular Devices Market

• Escalating Peripheral Artery Disease Prevalence: Rising aging population and increasing risk factors like diabetes, smoking, and hypertension drive PAD cases globally. The International Diabetes Federation projects diabetes cases will reach 643 million by 2030 and 783 million by 2045, significantly boosting demand for peripheral vascular devices.
• Technological Advancements in Device Innovation: Continuous R&D investments in enhanced imaging techniques, drug-coated balloons, and bioresorbable stents improve treatment efficacy. Advanced technologies enable more accurate interventions, better patient outcomes, and reduced need for repeat procedures, driving market expansion.
• Heightened Demand for Minimally Invasive Solutions: Cost-effectiveness, minimized recovery times, and reduced complication rates make minimally invasive procedures preferred treatment options. Healthcare systems focus on patient-specific treatments and successful outcomes, driving adoption of advanced atherectomy devices and angioplasty systems.
• Increasing Healthcare Infrastructure Development: Expanding medical facilities and improved access to vascular treatments in developing regions create new market opportunities. Government healthcare investments and infrastructure modernization programs support wider adoption of peripheral vascular devices globally.
• Growing Awareness and Early Diagnosis Initiatives: Enhanced awareness of peripheral artery disease among patients and healthcare providers promotes early diagnosis and intervention. Screening programs and educational campaigns increase patient identification, driving demand for diagnostic and treatment devices.

Get Instant Access to the Full Report with a Special Discount!

Leading Companies Operating in the Global Peripheral Vascular Devices Industry:

• Abbott Laboratories
• B. Braun SE
• Boston Scientific Corporation
• Cordis
• iVascular S.L.U.
• Medtronic plc
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• W. L. Gore & Associates, Inc.

Peripheral Vascular Devices Market Report Segmentation:

Breakup By Device Type:

• Peripheral Vascular Stents
• Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
• Peripheral Transluminal Angioplasty (PTA) Guidewires
• Atherectomy Devices
• Embolic Protection Devices
• Inferior Vena Cava Filters
• Others

Peripheral vascular stents account for the majority of shares due to their widespread use in treating arterial blockages and their proven efficacy in restoring blood flow.

Breakup By End User:

• Hospitals and Clinics
• Ambulatory Care Centers
• Specialty Clinics
• Others

Hospitals and clinics dominate the market due to their comprehensive infrastructure, specialized medical staff, and ability to handle complex peripheral vascular procedures.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position owing to advanced healthcare infrastructure, high prevalence of peripheral artery disease, and strong adoption of innovative medical technologies.

Recent News and Developments in Peripheral Vascular Devices Market

• November 2024: Abbott launched the latest generation of its Supera peripheral stent system with enhanced flexibility and deliverability, designed to improve outcomes in complex peripheral artery disease cases.
• October 2024: Boston Scientific introduced AI-enhanced angioplasty balloon catheters with real-time pressure monitoring and automated inflation control, reducing procedure complications by 18%.
• September 2024: Medtronic expanded its peripheral atherectomy device portfolio with next-generation rotational systems featuring improved debris removal efficiency and enhanced physician control mechanisms.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1–201971–6302